2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzo[d]oxazole

2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzo[d]oxazole Suppliers list
Company Name: Shanghai Balmxy Pharmaceutical Co., Ltd  
Tel: 021-24206007 13764915196
Email: sales@balmxy.com
Company Name: ShangHai AmK Pharmaceutical Technology Co., Ltd.  
Tel: 微信 18019252918 18019252918
Email: sale@amkchem.com
Company Name: Zhengzhou Alfachem Co., Ltd.  
Tel: 0371-53765687 18937137882
Email: 3969243885@qq.com
Company Name: BePharm Ltd  
Tel: 400-685-9117
Email: market@bepharm.com
Company Name: Amadis Chemical Company Limited  
Tel: 571-89925085
Email: sales@amadischem.com
2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzo[d]oxazole Basic information
Product Name:2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzo[d]oxazole
Synonyms:2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzo[d]oxazole;2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)oxazolo[5,4-b]pyridine;2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1,3-benzoxazole;Benzoxazole, 2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-;2-[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzoxazole
CAS:439090-73-0
MF:C19H20BNO3
MW:321.18
EINECS:
Product Categories:
Mol File:439090-73-0.mol
2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzo[d]oxazole Structure
2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzo[d]oxazole Chemical Properties
storage temp. under inert gas (nitrogen or Argon) at 2-8°C
AppearanceWhite to off-white Solid
Safety Information
MSDS Information
2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzo[d]oxazole Usage And Synthesis
Synthesis
2-(4-bromophenyl)benzo[d]oxazole

3164-13-4

Bis(pinacolato)diboron

73183-34-3

2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzo[d]oxazole

439090-73-0

2-(4-Bromophenyl)benzo[d]oxazole (5 g, 18.2 mmol), pinacol ester of bisboronic acid (5.1 g, 20.1 mmol) and potassium acetate (5.4 g, 54.7 mmol) were dissolved in 1,4-dioxane (182 ml) and stirred to mix. Subsequently, Pd(dppf)Cl2 (260 mg, 0.36 mmol) was added, and the reaction mixture was heated to 100 °C and stirred for 8 hours. After completion of the reaction, the reaction solution was cooled to room temperature. Water (100 ml) was added to the reaction solution and stirred for 10 min before extraction with tetrahydrofuran (THF). The organic layer was separated and the aqueous layer was discarded. The organic layer was dried with anhydrous magnesium sulfate (MgSO4) and subsequently concentrated. The concentrate was recrystallized with ethanol (150 ml) and filtered to give the target compound 2-(4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzo[d]oxazole (5.3 g, 90% yield). Mass spectrometry result: [M + H] = 322.

References[1] Patent: US2018/40829, 2018, A1. Location in patent: Paragraph 0167; 0168; 0169
[2] Patent: WO2011/8560, 2011, A1. Location in patent: Page/Page column 44
[3] Patent: WO2007/88148, 2007, A1. Location in patent: Page/Page column 27-28
[4] Patent: WO2011/34967, 2011, A1. Location in patent: Page/Page column 26
Tag:2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzo[d]oxazole(439090-73-0) Related Product Information
4-(2-Benzo[d]oxazolyl)phenylboronic acid 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]oxazole Benzoxazole, 2-phenyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)- 2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-6-Benzoxazolamine Furo[3,2-c]pyridine, 2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]- 2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-4-Benzoxazolamine